Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,532.00 DKK | -2.73% | -4.56% | +2.28% |
12:00am | Genmab A/S Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 03:00 PM | |
01-02 | A poor 2024 increases the odds of a brighter 2025 |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
16 | |||||||||
30 | |||||||||
24 | |||||||||
16 | |||||||||
20 | |||||||||
17 | |||||||||
22 | |||||||||
24 | |||||||||
- | - | - | - | - | - | 7 | |||
16 | |||||||||
21 | |||||||||
- | - | - | 9 | ||||||
22 | |||||||||
24 | |||||||||
- | - | - | - | ||||||
15 | |||||||||
5 | |||||||||
11 | |||||||||
15 | |||||||||
18 | |||||||||
Average | 17 | ||||||||
Weighted average by Cap. | 22 |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition